Is a Correction Looming Ahead for T2 Biosystems Inc. (TTOO) – News Heater
Home  »  Hot Stocks   »  Is a Correction Looming Ahead for T2 Biosystems In...

Is a Correction Looming Ahead for T2 Biosystems Inc. (TTOO)

T2 Biosystems Inc. (NASDAQ:TTOO) went down by -1.06% from its latest closing price compared to the recent 1-year high of $1.33. The company’s stock price has collected -0.47% of loss in the last five trading sessions.

Is It Worth Investing in T2 Biosystems Inc. (NASDAQ :TTOO) Right Now?

Plus, the 36-month beta value for TTOO is at 0.63.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


TTOO currently public float of 163.62M and currently shorts hold a 5.60% ratio of that float. Today, the average trading volume of TTOO was 1.79M shares.

TTOO’s Market Performance

TTOO stocks went down by -0.47% for the week, with a monthly drop of -20.66% and a quarterly performance of -60.52%, while its annual performance rate touched -86.21%. The volatility ratio for the week stands at 14.65% while the volatility levels for the past 30 days are set at 10.07% for T2 Biosystems Inc. The simple moving average for the period of the last 20 days is -10.92% for TTOO stocks with a simple moving average of -68.59% for the last 200 days.

Analysts’ Opinion of TTOO

Many brokerage firms have already submitted their reports for TTOO stocks, with Alliance Global Partners repeating the rating for TTOO by listing it as a “Neutral.” The predicted price for TTOO in the upcoming period, according to Alliance Global Partners is $2.40 based on the research report published on January 27th of the previous year 2021.

BTIG Research, on the other hand, stated in their research note that they expect to see TTOO reach a price target of $2.50. The rating they have provided for TTOO stocks is “Buy” according to the report published on October 08th, 2020.

TTOO Trading at -43.72% from the 50-Day Moving Average

After a stumble in the market that brought TTOO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -87.36% of loss for the given period.

Volatility was left at 10.07%, however, over the last 30 days, the volatility rate increased by 14.65%, as shares sank -22.42% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -66.36% lower at present.

During the last 5 trading sessions, TTOO fell by -0.47%, which changed the moving average for the period of 200-days by -81.74% in comparison to the 20-day moving average, which settled at $0.1864. In addition, T2 Biosystems Inc. saw -67.42% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at TTOO starting from Barclay Alec, who purchase 12,952 shares at the price of $0.50 back on Apr 08. After this action, Barclay Alec now owns 181,945 shares of T2 Biosystems Inc., valued at $6,476 using the latest closing price.

Sprague John M, the Chief Financial Officer of T2 Biosystems Inc., purchase 10,000 shares at $0.48 during a trade that took place back on Apr 08, which means that Sprague John M is holding 152,350 shares at $4,767 based on the most recent closing price.

Stock Fundamentals for TTOO

Current profitability levels for the company are sitting at:

  • -153.16 for the present operating margin
  • +26.21 for the gross margin

The net margin for T2 Biosystems Inc. stands at -175.50. Equity return is now at value 688.30, with -85.20 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 3.79.

Is Kimberly-Clark Corporation (KMB) a Keeper?

Kimberly-Clark Corporation (NYSE:KMB) went up by 3.54% from its latest closing price compared to the recent 1-year high of $145.79. The company’s stock price has